Maya Ridinger

Person

San Diego, CA, US

People

Patents Grantslast 30 patents

Information Patent Grant
PLK1 inhibitor in combination with anti-angiogenics for treating me...
- Patent number 12,144,813
- Issue date Nov 19, 2024
- Cardiff Oncology, Inc.
- Maya Ridinger
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Cancer treatment using FGFR inhibitors and PLK1 inhibitors
- Patent number 11,957,677
- Issue date Apr 16, 2024
- Cardiff Oncology, Inc.
- Maya Ridinger
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
PLK1 INHIBITOR IN COMBINATION WITH ANTI-ANGIOGENICS FOR TREATING ME...
- Publication number 20240352114
- Publication date Oct 24, 2024
- Cardiff Oncology, Inc.
- Maya Ridinger
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PLK1 INHIBITOR IN COMBINATION WITH ANTI-ANGIOGENICS FOR TREATING ME...
- Publication number 20240350499
- Publication date Oct 24, 2024
- Cardiff Oncology, Inc.
- Maya Ridinger
- C07 - ORGANIC CHEMISTRY
Information Patent Application
PLK1 INHIBITOR IN COMBINATION WITH ANTI-ANGIOGENICS FOR TREATING ME...
- Publication number 20240350500
- Publication date Oct 24, 2024
- Cardiff Oncology, Inc.
- Maya Ridinger
- C07 - ORGANIC CHEMISTRY
Information Patent Application
PLK1 INHIBITOR IN COMBINATION WITH ANTI-ANGIOGENICS FOR TREATING ME...
- Publication number 20240352115
- Publication date Oct 24, 2024
- Cardiff Oncology, Inc.
- Maya Ridinger
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PLK1 INHIBITOR IN COMBINATION WITH ANTI-ANGIOGENICS FOR TREATING ME...
- Publication number 20240350498
- Publication date Oct 24, 2024
- Cardiff Oncology, Inc.
- Maya RIDINGER
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CANCER TREATMENT USING PARP INHIBITORS AND PLK1 INHIBITORS
- Publication number 20240197730
- Publication date Jun 20, 2024
- Cardiff Oncology, Inc.
- Maya RIDINGER
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PLK1 INHIBITOR IN COMBINATION WITH ANTI-ANGIOGENICS FOR TREATING ME...
- Publication number 20240101656
- Publication date Mar 28, 2024
- Cardiff Oncology, Inc.
- Maya RIDINGER
- C07 - ORGANIC CHEMISTRY
Information Patent Application
PREDICTIVE BIOMARKERS FOR ONVANSERTIB TREATMENT
- Publication number 20230183814
- Publication date Jun 15, 2023
- Cardiff Oncology, Inc.
- Peter J.P. Croucher
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHODS OF MONITORING KRAS MUTATIONS
- Publication number 20230172935
- Publication date Jun 8, 2023
- Cardiff Oncology, Inc.
- Errin SAMUELSZ
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CIRCULATING TUMOR DNA AS A BIOMARKER FOR LEUKEMIA TREATMENT
- Publication number 20230167505
- Publication date Jun 1, 2023
- Cardiff Oncology, Inc.
- Errin SAMUELSZ
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
CANCER TREATMENT USING FGFR INHIBITORS AND PLK1 INHIBITORS
- Publication number 20230124366
- Publication date Apr 20, 2023
- Cardiff Oncology, Inc.
- Maya Ridinger
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TREATMENT OF LEUKEMIAS AND LYMPHOMAS WITH COMBINATIONS OF BCL-2 INH...
- Publication number 20230113501
- Publication date Apr 13, 2023
- Cardiff Oncology, Inc.
- Maya RIDINGER
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PLK1 INHIBITORS AND PSA LEVELS IN PROSTATE CANCER
- Publication number 20220184086
- Publication date Jun 16, 2022
- Cardiff Oncology, Inc.
- Mark Erlander
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ONVANSERTIB FOR INHIBITING NON-ADRENERGIC CONTRACTION OF SMOOTH MUS...
- Publication number 20220143021
- Publication date May 12, 2022
- Cardiff Oncology, Inc.
- Mark Erlander
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
SELECTION AND TREATMENT OF CANCER WITH COMBINATION THERAPIES
- Publication number 20220127682
- Publication date Apr 28, 2022
- Massachusetts Institute of Technology
- Michael B. Yaffe
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
PLK1 TARGET PHOSPHORYLATION STATUS AND TREATMENT OF CANCER WITH PLK...
- Publication number 20210222228
- Publication date Jul 22, 2021
- Cardiff Oncology, Inc.
- Maya Ridinger
- G01 - MEASURING TESTING

Maya Ridinger

Person

Patents Grantslast 30 patents

PLK1 inhibitor in combination with anti-angiogenics for treating me...

Cancer treatment using FGFR inhibitors and PLK1 inhibitors

Patents Applicationslast 30 patents

PLK1 INHIBITOR IN COMBINATION WITH ANTI-ANGIOGENICS FOR TREATING ME...

PLK1 INHIBITOR IN COMBINATION WITH ANTI-ANGIOGENICS FOR TREATING ME...

PLK1 INHIBITOR IN COMBINATION WITH ANTI-ANGIOGENICS FOR TREATING ME...

PLK1 INHIBITOR IN COMBINATION WITH ANTI-ANGIOGENICS FOR TREATING ME...

PLK1 INHIBITOR IN COMBINATION WITH ANTI-ANGIOGENICS FOR TREATING ME...

CANCER TREATMENT USING PARP INHIBITORS AND PLK1 INHIBITORS

PLK1 INHIBITOR IN COMBINATION WITH ANTI-ANGIOGENICS FOR TREATING ME...

PREDICTIVE BIOMARKERS FOR ONVANSERTIB TREATMENT

METHODS OF MONITORING KRAS MUTATIONS

CIRCULATING TUMOR DNA AS A BIOMARKER FOR LEUKEMIA TREATMENT

CANCER TREATMENT USING FGFR INHIBITORS AND PLK1 INHIBITORS

TREATMENT OF LEUKEMIAS AND LYMPHOMAS WITH COMBINATIONS OF BCL-2 INH...

PLK1 INHIBITORS AND PSA LEVELS IN PROSTATE CANCER

ONVANSERTIB FOR INHIBITING NON-ADRENERGIC CONTRACTION OF SMOOTH MUS...

SELECTION AND TREATMENT OF CANCER WITH COMBINATION THERAPIES

PLK1 TARGET PHOSPHORYLATION STATUS AND TREATMENT OF CANCER WITH PLK...